
PTSM: Pharmaceutical Technology Sourcing and Management
- PTSM: Pharmaceutical Technology Sourcing and Management-08-03-2016
- Volume 11
- Issue 8
Shimadzu System Combines HPLC and UHPLC Methods
The Nexera-i MT from Shimadzu incorporates two flow lines, which allow for both UHPLC and HPLC analysis.
The Nexera-i MT from Shimadzu supports the transfer of existing high-performance liquid chromatography (HPLC) to faster ultra-high pressure liquid chormatography (UHPLC) methods while assuring cross-compatibility. The system’s analytical conditions transfer and optimization (ACTO) technology minimizes the effect of system volume differences on analytical results. The ACTO technology adjusts injection timing based on the system volume difference between existing HPLC system and Nexera-i MT without modification to the gradient program.
The Nexera-i MT features two independent flow lines, for UHPLC and HPLC analyses. The system can switch between flow lines and automatically compensates for differences in system volume, preserving relative separation patterns. It also allows for efficient switching between large- and small-volume systems. Users can transfer UHPLC and HPLC methods from other systems to the Nexera-i MT without the need for modification. The system includes fully automated system startup, baseline stabilization, and user interfaces. Users can modify analytical methods using the Nexera-i MT’s touchscreen control panel.
Source:
Articles in this issue
about 9 years ago
Slower Bio/Pharma Investment Could Hurt CDMOs in 2017about 9 years ago
Supply Chain Partner Scrutiny Moves Beyond GMPsabout 9 years ago
Chiral Advances Demonstrate Promise for API Synthesisover 9 years ago
NIST Issues mAb Reference Standardover 9 years ago
EMA Suspends Drugs Due to Flawed Bioequivalence Studiesover 9 years ago
CordenPharma Expands into Oligonucleotide APIsover 9 years ago
Catalent to Commercially Supply Palatin FSD Pen Injectorsover 9 years ago
Zenith Appoints Serialization Directorover 9 years ago
CSafe Opens Facility in Puerto RicoNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




